Cargando…

Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review

A mucormycosis surge was reported during the COVID-19 pandemic in India. A literature search until 14 July 2022, with the aim of updating COVID-19-associated mucormycosis (CAM), identified 663 studies and 88 met inclusion criteria (8727 patients). India reported 8388 patients, Egypt 208 and Europe 4...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almyroudi, Maria Panagiota, Akinosoglou, Karolina, Rello, Jordi, Blot, Stijn, Dimopoulos, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777018/ https://www.ncbi.nlm.nih.gov/pubmed/36553099 http://dx.doi.org/10.3390/diagnostics12123092

Ejemplares similares

COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Dimopoulos, George, et al.
Publicado: (2021)

Targeting CMV Reactivation to Optimize Care for Critically Ill COVID-19 Patients: A Review on the Therapeutic Potential of Antiviral Treatment
por: Schinas, Georgios, et al.
Publicado: (2023)

The impact of age on intensive care
por: Akinosoglou, Karolina, et al.
Publicado: (2023)

A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Feys, Simon, et al.
Publicado: (2021)

The value of polyurethane-cuffed endotracheal tubes to reduce microaspiration and intubation-related pneumonia: a systematic review of laboratory and clinical studies
por: Blot, Stijn I., et al.
Publicado: (2016)

COVID-19 associated Mucormycosis (CAM): Should Brazil be on alert?
por: Farias, Luís Arthur Brasil Gadelha, et al.
Publicado: (2021)

COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping
por: Hussain, Salman, et al.
Publicado: (2021)

COVID-19 associated mucormycosis (CAM): A tale of two pathogens
por: Pustake, Manas, et al.
Publicado: (2021)

COVID-19 associated mucormycosis (CAM) in India: a formidable challenge
por: Rao, Vishal U.S., et al.
Publicado: (2021)

Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir
por: Akinosoglou, Karolina, et al.
Publicado: (2022)

Epidemiology and Resistance Phenotypes of Carbapenem-Resistant Klebsiella pneumoniae in Corfu General Hospital (2019–2022): A Comprehensive Time Series Analysis of Resistance Gene Dynamics
por: Sorovou, Glykeria, et al.
Publicado: (2023)

COVID-19 associated Mucormycosis (CAM): Implications for perioperative physicians – A narrative review
por: Gupta, Anju, et al.
Publicado: (2023)

Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: probing the triggering factors
por: Arakeri, Gururaj, et al.
Publicado: (2022)

326. Radiologic Findings of COVID-19 Associated Mucormycosis (CAM) from India
por: Govindaraju, Aswath, et al.
Publicado: (2021)

COVID-19 Associated Mucormycosis (CAM): A Single Hospital-Based Study
por: Vijapur, Manjunath M., et al.
Publicado: (2022)

Novel Antimicrobial Agents for Gram-Negative Pathogens
por: Karvouniaris, Marios, et al.
Publicado: (2023)

COVID-associated mucormycosis (CAM): is the Delta variant a cause?
por: Arakeri, Gururaj, et al.
Publicado: (2022)

Preventing Multidrug-Resistant Bacterial Transmission in the Intensive Care Unit with a Comprehensive Approach: A Policymaking Manual
por: Schinas, Georgios, et al.
Publicado: (2023)

Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature
por: Garg, Deepak, et al.
Publicado: (2021)

Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis
por: Hussain, Salman, et al.
Publicado: (2021)

A peek behind the curtain in the diagnosis and management of COVID‑19‑Associated Mucormycosis (CAM)
por: Osman, Nermin A., et al.
Publicado: (2023)

Understanding and Implementing Diagnostic Stewardship: A Guide for Resident Physicians in the Era of Antimicrobial Resistance
por: Schinas, Georgios, et al.
Publicado: (2023)

COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors
por: Riad, Abanoub, et al.
Publicado: (2021)

Zygomaticomaxillary Osteomyelitis due to COVID-19 Associated Mucormycosis (CAM): A Case Series of 10 Patients
por: Datarkar, Abhay N., et al.
Publicado: (2022)

Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study
por: Tavakolpour, Soheil, et al.
Publicado: (2022)

P174 Prevalence and outcomes of patients with COVID - associated mucormycosis (CAM): A case series
por: Chakraborty, Sangeeta, et al.
Publicado: (2022)

Transcaruncular medial orbitotomy: A globe sparing intervention in management of COVID associated mucormycosis [CAM]
por: Katti, Venkatram, et al.
Publicado: (2023)

Diabetes mellitus and Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): A wake-up call from Egypt
por: Alfishawy, Mostafa, et al.
Publicado: (2021)

Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes
por: Taccone, Fabio Silvio, et al.
Publicado: (2015)

Understanding resistance in Pseudomonas
por: Dimopoulos, George, et al.
Publicado: (2020)

Accidental finding of COVID‐associated mucormycosis (CAM) in a patient presenting as toothache: A case report and review of literature
por: GB, Protyusha, et al.
Publicado: (2023)

Covid-19 vaccine and autoimmunity: Awakening the sleeping dragon
por: Akinosoglou, Karolina, et al.
Publicado: (2021)

Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study
por: Blot, Stijn, et al.
Publicado: (2014)

Investigation of an acute surge of COVID-19 associated mucormycosis (CAM) cases reported to a tertiary health care institution in Bihar, India
por: Singh, Chandra Mani, et al.
Publicado: (2022)

Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital–cerebral mucormycosis: preserving the salvageable
por: Keshri, Amit, et al.
Publicado: (2022)

Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
por: Azhar, Asim, et al.
Publicado: (2022)

COVID-19 and orbital mucormycosis
por: Sarkar, Sandip, et al.
Publicado: (2021)

Mucormycosis in COVID-19 patients
por: Sundaram, Natarajan, et al.
Publicado: (2021)

COVID-19 Associated Mucormycosis
por: Tazeem, Sana, et al.
Publicado: (2023)

Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers
por: Rello, Jordi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h5satgfqf5k5bchj0gihjg0amb